Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Current Pharmaceutical Design|February 3, 2007
Design of second generation HIV-1 integrase inhibitorsJinxia Deng, Raveendra Dayam, Laith Q Al-Mawsawi, et al.Chemmedchem|April 3, 2008
Naphthoxazepine inhibitors of HIV-1 integrase: synthesis and biological evaluationAntonio Garofalo, Fedora Grande, Antonella Brizzi, et al.Journal of Medicinal Chemistry|January 7, 2005
Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitorsRaveendra Dayam, Tino Sanchez, Omoshile Clement, et al.Virology|June 3, 2008
Four-tiered pi interaction at the dimeric interface of HIV-1 integrase critical for DNA integration and viral infectivityLaith Q Al-Mawsawi, Anneleen Hombrouck, Raveendra Dayam, et al.FEBS Letters|March 12, 2008
Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysisLaith Q Al-Mawsawi, Frauke Christ, Raveendra Dayam, et al.Bioorganic & Medicinal Chemistry|July 22, 2004
Synthesis of novel thiazolothiazepine based HIV-1 integrase inhibitorsFrancesca Aiello, Antonella Brizzi, Antonio Garofalo, et al.Journal of Medicinal Chemistry|July 21, 2006
Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agentsRaveendra Dayam, Francesca Aiello, Jinxia Deng, et al.Journal of Medicinal Chemistry|February 20, 2008
Quinolone 3-carboxylic acid pharmacophore: design of second generation HIV-1 integrase inhibitorsRaveendra Dayam, Laith Q Al-Mawsawi, Zahrah Zawahir, et al.Bioorganic & Medicinal Chemistry Letters|October 24, 2007
Discovery of novel non-cytotoxic salicylhydrazide containing HIV-1 integrase inhibitorsLaith Q Al-Mawsawi, Raveendra Dayam, Laleh Taheri, et al.Molecular Cancer Therapeutics|July 16, 2005
Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell linesCarmen Plasencia, Raveendra Dayam, Qingcai Wang, et al.Pageof 4